Skip to main content

Effect of platelet glycoprotein (GP) IIb/IIIa antagonism with integrilin on activated clotting times during coronary interventions: Results from the IMPACT II trial

Publication ,  Journal Article
Aguirre, FV; Topol, EJ; Ferguson, JJ; Blankenship, JC; Gardner, LH; Caracciolo, EA; Donohue, TJ; Harrington, RA; Tcheng, JE
Published in: CIRCULATION
October 15, 1996

Duke Scholars

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 15, 1996

Volume

94

Issue

8

Start / End Page

1148 / 1148

Publisher

AMER HEART ASSOC

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Aguirre, F. V., Topol, E. J., Ferguson, J. J., Blankenship, J. C., Gardner, L. H., Caracciolo, E. A., … Tcheng, J. E. (1996). Effect of platelet glycoprotein (GP) IIb/IIIa antagonism with integrilin on activated clotting times during coronary interventions: Results from the IMPACT II trial. CIRCULATION, 94(8), 1148–1148.
Aguirre, F. V., E. J. Topol, J. J. Ferguson, J. C. Blankenship, L. H. Gardner, E. A. Caracciolo, T. J. Donohue, R. A. Harrington, and J. E. Tcheng. “Effect of platelet glycoprotein (GP) IIb/IIIa antagonism with integrilin on activated clotting times during coronary interventions: Results from the IMPACT II trial.” CIRCULATION 94, no. 8 (October 15, 1996): 1148–1148.
Aguirre FV, Topol EJ, Ferguson JJ, Blankenship JC, Gardner LH, Caracciolo EA, et al. Effect of platelet glycoprotein (GP) IIb/IIIa antagonism with integrilin on activated clotting times during coronary interventions: Results from the IMPACT II trial. CIRCULATION. 1996 Oct 15;94(8):1148–1148.
Aguirre FV, Topol EJ, Ferguson JJ, Blankenship JC, Gardner LH, Caracciolo EA, Donohue TJ, Harrington RA, Tcheng JE. Effect of platelet glycoprotein (GP) IIb/IIIa antagonism with integrilin on activated clotting times during coronary interventions: Results from the IMPACT II trial. CIRCULATION. AMER HEART ASSOC; 1996 Oct 15;94(8):1148–1148.

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 15, 1996

Volume

94

Issue

8

Start / End Page

1148 / 1148

Publisher

AMER HEART ASSOC

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology